April 28, 2022
Seer to Present at the BofA Securities 2022 Healthcare Conference
April 7, 2022
Seer to Report First Quarter Financial Results on May 4, 2022
March 16, 2022
Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer
March 14, 2022
Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences
February 28, 2022
Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook
February 22, 2022
Seer to Present at the Cowen 42nd Annual Health Care Conference
February 1, 2022
Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
January 10, 2022
Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program
January 10, 2022
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
Pagination